Success Metrics

Clinical Success Rate
87.0%

Based on 281 completed trials

Completion Rate
87%(281/323)
Active Trials
61(12%)
Results Posted
39%(110 trials)
Terminated
42(8%)

Phase Distribution

Ph early_phase_1
19
4%
Ph phase_2
96
18%
Ph not_applicable
73
14%
Ph phase_1
48
9%
Ph phase_3
98
19%
Ph phase_4
173
33%

Phase Distribution

67

Early Stage

96

Mid Stage

271

Late Stage

Phase Distribution507 total trials
Early Phase 1First-in-human
19(3.7%)
Phase 1Safety & dosage
48(9.5%)
Phase 2Efficacy & side effects
96(18.9%)
Phase 3Large-scale testing
98(19.3%)
Phase 4Post-market surveillance
173(34.1%)
N/ANon-phased studies
73(14.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.4%

281 of 341 finished

Non-Completion Rate

17.6%

60 ended early

Currently Active

61

trials recruiting

Total Trials

524

all time

Status Distribution
Active(79)
Completed(281)
Terminated(60)
Other(104)

Detailed Status

Completed281
unknown104
Recruiting50
Terminated42
Withdrawn18
Not yet recruiting17

Development Timeline

Analytics

Development Status

Total Trials
524
Active
61
Success Rate
87.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 119 (3.7%)
Phase 148 (9.5%)
Phase 296 (18.9%)
Phase 398 (19.3%)
Phase 4173 (34.1%)
N/A73 (14.4%)

Trials by Status

enrolling_by_invitation10%
not_yet_recruiting173%
completed28154%
active_not_recruiting112%
recruiting5010%
withdrawn183%
unknown10420%
terminated428%

Recent Activity

Clinical Trials (524)

Showing 20 of 524 trialsScroll for more
NCT05962034Phase 4

Thromboxane Function in Women With Endometriosis

Completed
NCT06494878Phase 3

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

Recruiting
NCT07686770Phase 2

Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease

Not Yet Recruiting
NCT07597239Not Applicable

Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization

Active Not Recruiting
NCT07719894Phase 4

Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes

Recruiting
NCT07720934Not Applicable

A Pilot Study to Investigate Platelet Reactivity in Patients With Elevated Lipoprotein(a) and Its Response to Antiplatelet Therapy

Not Yet Recruiting
NCT06108947Not Applicable

Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks

Recruiting
NCT06638151Phase 2

Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)

Completed
NCT07431762Phase 4

Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprosthetic Heart Valve Replacement

Recruiting
NCT06676280Phase 4

ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography

Recruiting
NCT07677410Not Applicable

Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation

Not Yet Recruiting
NCT03805932Phase 1

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

Active Not Recruiting
NCT05418556Phase 4

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Recruiting
NCT04145258Phase 3

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

Recruiting
NCT05056896Early Phase 1

ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

Active Not Recruiting
NCT07658807Phase 3

Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease

Not Yet Recruiting
NCT02521285Phase 2

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

Active Not Recruiting
NCT07652723Phase 1

A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants

Recruiting
NCT04695106Phase 4

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

Recruiting
NCT07644234Phase 4

Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
524